Intracranial Atherosclerosis Disease: A Preventable Epidemic.
作者信息
Moonis Majaz
机构信息
Professor of Neurology and Psychiatry, Director of Stroke Services and Fellowship Program, UMass Memorial Medical Center, Worcester, Massachusetts, USA.
Director of Stroke and Sleep Programs, Day Kimball Hospital, Putnam Connecticut, Putnam, CT, USA.
出版信息
Ann Indian Acad Neurol. 2020 May-Jun;23(3):246-247. doi: 10.4103/aian.AIAN_82_20. Epub 2020 Jun 10.
Abstract
摘要
相似文献
1
Intracranial Atherosclerosis Disease: A Preventable Epidemic.颅内动脉粥样硬化疾病：一种可预防的流行病。
Ann Indian Acad Neurol. 2020 May-Jun;23(3):246-247. doi: 10.4103/aian.AIAN_82_20. Epub 2020 Jun 10.
2
Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study.缺血性中风亚型复发的机制：一项基于医院的随访研究。
Arch Neurol. 2005 Aug;62(8):1232-7. doi: 10.1001/archneur.62.8.1232.
3
The population-based Barcelona-Asymptomatic Intracranial Atherosclerosis Study (ASIA): rationale and design.基于人群的巴塞罗那无症状颅内动脉粥样硬化研究（ASIA）：原理和设计。
BMC Neurol. 2011 Feb 17;11:22. doi: 10.1186/1471-2377-11-22.
4
Combined extracranial and intracranial atherosclerosis in Korean patients.韩国患者的颅外和颅内动脉粥样硬化合并症
Arch Neurol. 2003 Nov;60(11):1561-4. doi: 10.1001/archneur.60.11.1561.
5
Intracranial Atherosclerotic Burden on 7T MRI Is Associated with Markers of Extracranial Atherosclerosis: The SMART-MR Study.7T MRI 颅内动脉粥样硬化负荷与颅外动脉粥样硬化标志物相关：SMART-MR 研究。
AJNR Am J Neuroradiol. 2019 Dec;40(12):2016-2022. doi: 10.3174/ajnr.A6308. Epub 2019 Dec 5.
6
Identification of co-expressed central genes and transcription factors in atherosclerosis-related intracranial aneurysm.动脉粥样硬化相关颅内动脉瘤中共表达核心基因和转录因子的鉴定
Front Neurol. 2023 Mar 2;14:1055456. doi: 10.3389/fneur.2023.1055456. eCollection 2023.
7
Decrease in circulating myeloid dendritic cell precursors in patients with intracranial large artery atherosclerosis.颅内大动脉粥样硬化患者循环髓样树突状细胞前体减少。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11495-502. eCollection 2015.
8
The Barcelona-Asymptomatic Intracranial Atherosclerosis study: Subclinical intracranial atherosclerosis as predictor of long-term vascular events.巴塞罗那无症状颅内动脉粥样硬化研究：亚临床颅内动脉粥样硬化作为长期血管事件的预测指标。
Atherosclerosis. 2019 Mar;282:132-136. doi: 10.1016/j.atherosclerosis.2019.01.022. Epub 2019 Jan 29.
9
Relation between interleukin-6 level and subclinical intracranial large-artery atherosclerosis.白细胞介素-6水平与亚临床颅内大动脉粥样硬化之间的关系。
Atherosclerosis. 2008 Mar;197(1):326-32. doi: 10.1016/j.atherosclerosis.2007.05.013. Epub 2007 Jun 29.
10
Intracranial Atherosclerosis: From Microscopy to High-Resolution Magnetic Resonance Imaging.颅内动脉粥样硬化：从显微镜检查到高分辨率磁共振成像
J Stroke. 2017 Sep;19(3):249-260. doi: 10.5853/jos.2016.01956. Epub 2017 Sep 6.
引用本文的文献
1
A multicenter analysis to identify the risk factors for stroke recurrence and mortality within 1 year.一项多中心分析，旨在确定1年内中风复发和死亡的危险因素。
Front Neurol. 2025 Feb 5;16:1478175. doi: 10.3389/fneur.2025.1478175. eCollection 2025.
本文引用的文献
1
Comparison of Risk Factors, Treatment, and Outcome in Patients with Symptomatic Intracranial Atherosclerotic Disease in India and the United States.印度和美国有症状颅内动脉粥样硬化疾病患者的危险因素、治疗及预后比较
Ann Indian Acad Neurol. 2020 May-Jun;23(3):265-269. doi: 10.4103/aian.AIAN_549_19. Epub 2020 Jun 5.
2
Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.氯吡格雷联合阿司匹林用于轻度卒中或短暂性脑缺血发作的疗效：氯吡格雷用于急性非致残性脑血管事件高危患者（CHANCE）及新发性短暂性脑缺血发作和轻度缺血性卒中血小板靶向抑制（POINT）试验的汇总分析
JAMA Neurol. 2019 Dec 1;76(12):1466-1473. doi: 10.1001/jamaneurol.2019.2531.
3
Association of dietary patterns and dietary diversity with cardiometabolic disease risk factors among adults in South Asia: The CARRS study.南亚成年人饮食模式和饮食多样性与心血管代谢疾病风险因素的关联：CARRS研究
Asia Pac J Clin Nutr. 2018;27(6):1332-1343. doi: 10.6133/apjcn.201811_27(6).0021.
4
Statin Adherence Is Associated With Reduced Recurrent Stroke Risk in Patients With or Without Atrial Fibrillation.他汀类药物的依从性与伴有或不伴有心房颤动的患者复发性卒中风险的降低相关。
Stroke. 2017 Jul;48(7):1788-1794. doi: 10.1161/STROKEAHA.117.017343. Epub 2017 Jun 8.
5
Barriers and Facilitators for Type-2 Diabetes Management in South Asians: A Systematic Review.南亚2型糖尿病管理的障碍与促进因素：一项系统综述
PLoS One. 2015 Sep 18;10(9):e0136202. doi: 10.1371/journal.pone.0136202. eCollection 2015.
6
Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID?患者特征能否解释SAMMPRIS和WASID研究中接受药物治疗患者的结局差异？
Stroke. 2015 Sep;46(9):2562-7. doi: 10.1161/STROKEAHA.115.009656. Epub 2015 Aug 6.
7
Risk factors and clinical outcomes associated with intracranial and extracranial atherosclerotic stenosis acute ischemic stroke.颅内和颅外动脉粥样硬化狭窄性急性缺血性脑卒中的相关风险因素和临床结局。
J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):1112-7. doi: 10.1016/j.jstrokecerebrovasdis.2013.09.024. Epub 2013 Nov 1.
8
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.高风险颅内动脉狭窄患者（SAMMPRIS）强化药物治疗联合或不联合支架置入的疗效：一项随机试验的最终结果。
Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26.
9
Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment.动脉粥样硬化性颅内动脉狭窄：危险因素、诊断与治疗。
Lancet Neurol. 2013 Nov;12(11):1106-14. doi: 10.1016/S1474-4422(13)70195-9.
Zotero 插件